Jazz Pharmaceuticals Advances Recombinant Crisantaspase Development Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 205.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $205.70 | 52 Week High | $160.00 | |||
| Open | $205.70 | 52 Week Low | $95.80 | |||
| Day High | $205.70 | P/E | 38.23 | |||
| Day Low | $205.70 | EPS | $5.38 | |||
| Volume | 1,065 | |||||
